Pembrolizumab-induced lichen planus pemphigoides in a patient with metastatic melanoma

MeSH terms

• Antibodies, Monoclonal, Humanized / adverse effects*
• Antibodies, Monoclonal, Humanized / therapeutic use
• Complement C3 / metabolism
• Dapsone / therapeutic use
• Dose-Response Relationship, Drug
• Double-Blind Method
• Drug Hypersensitivity / drug therapy
• Drug Hypersensitivity / pathology*
• Fluorescent Antibody Technique, Direct
• Follow-Up Studies
• Humans
• Lichen Planus / chemically induced*
• Lichen Planus / drug therapy
• Lichen Planus / pathology
• Male
• Melanoma / drug therapy*
• Melanoma / pathology
• Middle Aged
• Mouth Mucosa / drug effects
• Mouth Mucosa / pathology
• Neoplasm Metastasis
• Neoplasm Staging
• Pemphigoid, Bullous / chemically induced*
• Pemphigoid, Bullous / drug therapy
• Pemphigoid, Bullous / pathology
• Skin / drug effects
• Skin / pathology
• Skin Neoplasms / drug therapy*
• Skin Neoplasms / pathology
• Stomatitis / chemically induced
• Stomatitis / drug therapy
• Stomatitis / pathology